Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis

WFW Bierman; EH Humphreys; MA van Agtmael; CA Boucher; GW Rutherford

首页> 外文期刊>Journal of the International Aids Society >Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis

【24h】

Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis

机译：在荟萃分析中，利托那韦增强蛋白酶抑制剂的单一疗法比联合抗逆转录病毒疗法的疗效低6％

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of the International Aids Society》 |2010年第4期|共页
作者
WFW Bierman; EH Humphreys; MA van Agtmael; CA Boucher; GW Rutherford;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类流行病学与防疫;
关键词

相似文献

外文文献
中文文献
专利

1. Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors [J] . Calza Leonardo, Danese Ilaria, Magistrelli Eleonora, HIV clinical trials . 2016,第1期

机译：Raltegravir-Darunavir / Ritonavir双重组合在抗逆转录病毒疗法中被病毒学抑制的HIV-1感染患者，包括利托那韦增强的蛋白酶抑制剂和两种核苷/核苷酸逆转录酶抑制剂。
2. Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial [J] . Arenas-Pinto Alejandro, Stohr Wolfgang, Jager Hans Rolf, Clinical infectious diseases . 2016,第2期

机译：病毒学抑制的HIV阳性患者的神经认知功能和神经影像标记物随机分配到利托那韦增强蛋白酶抑制剂单一疗法或标准联合用药治疗：PIVOT试验的横断面研究
3. Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial [J] . Arenas-Pinto Alejandro, Stohr Wolfgang, Jager Hans Rolf, Clinical infectious diseases . 2016,第2期

机译：病毒学抑制的神经认知功能和神经影像标记物在病毒抑制的艾滋病毒阳性患者中随机化为Ritonavir - 促进蛋白酶抑制剂单疗法或标准组合艺术：来自枢轴试验的横截面血底
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. The evaluation of anti-cancer effects of FL118 in retinoblastoma in monotherapy and combination therapies. [D] . Singh, Jasman Kaur. 2014

机译：在单一疗法和联合疗法中评估FL118在视网膜母细胞瘤中的抗癌作用。
6. Ritonavir-boosted protease inhibitor monotherapy is 6 less effective than combination antiretroviral therapy in a meta-analysis [O] . WFW Bierman, EH Humphreys, MA van Agtmael, 2010

机译：在荟萃分析中利托那韦增强蛋白酶抑制剂的单一疗法比联合抗逆转录病毒疗法的疗效低6％
7. Ritonavir-boosted protease inhibitor monotherapy is 6 less effective than combination antiretroviral therapy in a meta-analysis [O] . WFW Bierman, EH Humphreys, MA van Agtmael, 2010

机译：在荟萃分析中，利托那韦增强蛋白酶抑制剂的单一疗法比联合抗逆转录病毒疗法的疗效低6％
8. PRAM-2: A Phase I/II Randomized, Multicenter Protocol Comparing Four Antiretroviral Regimens Containing Combinations of Protease Inhibitors, NRTIs and an NNRTI Documentation. Version 3.0 [R] . Wiznia, A., Johnson, G. M., Krogstad, P. 1999

机译：pRam-2：I / II期随机，多中心方案比较四种含有蛋白酶抑制剂，NRTI和NNRTI文献组合的抗逆转录病毒方案。版本3.0

Ritonavir-boosted protease inhibitor monotherapy is 6% less effective than combination antiretroviral therapy in a meta-analysis

著录项

相似文献

相关主题

期刊订阅